Functional Electrical Stimulation for Multiple Sclerosis

(FES in MS Trial)

This trial explores how well functional electrical stimulation (FES) aids people with multiple sclerosis (MS) in improving their walking. MS can cause foot drop, which hinders walking and raises the risk of falling. The trial compares FES to a sham (fake) treatment to determine its true impact on mobility and daily life over several months. People with MS who have difficulty walking and haven't recently used FES might be suitable candidates for this trial. As an unphased trial, this study provides a unique opportunity for participants to contribute to understanding how FES can enhance mobility in MS patients.

The trial does not specify that you need to stop taking your current medications. It mentions that participants can be on any MS therapy or no disease-modifying treatment.

Research has shown that Functional Electrical Stimulation (FES) is generally safe for people with multiple sclerosis (MS). One study found FES safe for those with a disability score of less than 6.5 on a specific scale, indicating many people with MS can use it without issues. Another study assessed safety by examining side effects or increases in MS symptoms. The results showed that FES did not cause serious side effects or worsen MS symptoms, both immediately after use and the following day. Additionally, NICE, a health authority in the UK, considers FES safe and effective enough to be regularly offered to MS patients. These findings suggest that FES can be a safe option for people with MS seeking to improve their mobility.¹²³⁴⁵

Functional Electrical Stimulation (FES) is unique because it offers a non-invasive way to help manage multiple sclerosis (MS) symptoms by using electrical impulses to stimulate muscles. Unlike traditional medications that primarily target inflammation and immune response, FES directly addresses muscle weakness and mobility issues, which are common in MS. Researchers are excited about FES because it has the potential to improve muscle strength and enhance mobility without the side effects associated with many pharmaceuticals. This approach could offer a complementary option to existing MS treatments, providing a new avenue for improving quality of life for patients.

This trial will compare the effects of Functional Electrical Stimulation (FES) with a sham treatment for people with multiple sclerosis (MS). Studies have shown that FES can significantly improve walking speed in individuals with MS. For example, some patients experienced a 27% increase in walking speed after 20 weeks of FES treatment. Research also indicates that FES can ease walking and enhance overall quality of life by reducing foot drop, a common MS issue where the front part of the foot drops due to weakness. Long-term studies suggest these benefits can persist, with some patients maintaining improved walking speed even after five years. FES may also help reduce muscle stiffness, fatigue, and pain, further enhancing mobility and comfort.⁶⁷⁸⁹¹⁰